Correlation Between Ikena Oncology and Akari Therapeutics
Can any of the company-specific risk be diversified away by investing in both Ikena Oncology and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ikena Oncology and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ikena Oncology and Akari Therapeutics PLC, you can compare the effects of market volatilities on Ikena Oncology and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ikena Oncology with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ikena Oncology and Akari Therapeutics.
Diversification Opportunities for Ikena Oncology and Akari Therapeutics
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Ikena and Akari is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Ikena Oncology and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and Ikena Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ikena Oncology are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of Ikena Oncology i.e., Ikena Oncology and Akari Therapeutics go up and down completely randomly.
Pair Corralation between Ikena Oncology and Akari Therapeutics
Given the investment horizon of 90 days Ikena Oncology is expected to generate 0.94 times more return on investment than Akari Therapeutics. However, Ikena Oncology is 1.07 times less risky than Akari Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Akari Therapeutics PLC is currently generating about -0.03 per unit of risk. If you would invest 274.00 in Ikena Oncology on September 4, 2024 and sell it today you would lose (103.00) from holding Ikena Oncology or give up 37.59% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.8% |
| Values | Daily Returns |
Ikena Oncology vs. Akari Therapeutics PLC
Performance |
| Timeline |
| Ikena Oncology |
| Akari Therapeutics PLC |
Ikena Oncology and Akari Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ikena Oncology and Akari Therapeutics
The main advantage of trading using opposite Ikena Oncology and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ikena Oncology position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.| Ikena Oncology vs. Candel Therapeutics | Ikena Oncology vs. Cingulate Warrants | Ikena Oncology vs. Unicycive Therapeutics | Ikena Oncology vs. Cardio Diagnostics Holdings |
| Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |